Phase 2Recruiting

Endocannabinoids in Reward

The Contribution of the Endocannabinoid System to Sex Differences in THC-associated Reward

Sponsor
Medical University of South Carolina (Academic or other)
Enrollment
78 planned
Conditions
Cannabis Use Disorder
Interventions
Dronabinol; Placebo
Ages
adults
Registry
NCT07815691

Full record on ClinicalTrials.gov

From the registry

This study will examine sex differences in the effects of cannabis in people that regularly use it. Men and women that use cannabis at least 4 days a week will participate in a study involving 3 in-person visits. The first visit will be used to determine eligibility for the study. The other two visits will last 7 hours each and take place at least two days apart. Visits include administration of either THC, the chemical responsible for many of the psychoactive effects of cannabis, or a placebo; completion of questionnaires; and a 1-hour brain scan. One visit will also include a blood draw for genetic testing.

Primary outcomes

  • Nucleus accumbens glutamate
  • Drug Effects Questionnaire (DEQ) - Like Drug Effect
  • Sex differences in genetics

History

  1. Primary completion expected

  2. Last registry update

  3. Started

  4. Registered